Recent Advances and Future Perspective of DC-Based Therapy in NSCLC

Current treatment for patients with non-small-cell lung cancer (NSCLC) is suboptimal since therapy is only effective in a minority of patients and does not always induce a long-lasting response. This highlights the importance of exploring new treatment options. The clinical success of immunotherapy...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: van der Hoorn, Iris A. E., Flórez-Grau, Georgina, van den Heuvel, Michel M., de Vries, I. Jolanda M., Piet, Berber
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8273436/
https://ncbi.nlm.nih.gov/pubmed/34262573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.704776
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki